Pharmacovigilance, also known as drug safety, is the pharmacological science relating to the collection, detection, causality assessment, monitoring, and prevention of adverse effects when pharmaceutical products are used in humans.
Information is received (i.e., collection of information) from various sources including patients, consumers, physicians, nurses, pharmacist and other healthcare professionals and this plays a critical role in providing the data necessary for pharmacovigilance activity to take place.
Once the information is received/collected, a Drug Safety Physician/doctor (MBBS /MD) will review the data to assess the causality of the adverse event/side effect in relationship to the drug administered.
Most of the times, the initial information provided would be insufficient to make a proper causality assessment.
More and more medical information may be required to make a proper causality assessment. In such scenarios, healthcare professionals like doctors and nurses who can really understand the disease state, the effect of the drugs and other comorbid conditions will have to follow up with the reporters, talk to them and enquire about the earlier reported adverse events and all other relevant medical information pertaining to the adverse event.
Once this is done, all the information that has been collected has to be documented and sent further for causality assessment by the pharmacovigilance physician.
Report follow-up: A part of routine pharmacovigilance that is aimed at obtaining further relevant information about an adverse drug reaction case from the reporting health care professional.]]>
Seniority Level
Entry level
Industry
- Biotechnology
- Hospital & Health Care
- Pharmaceuticals
Employment Type
Full-time
Job Functions
- Research
- Analyst
- Information Technology
Place
No comments:
Post a Comment